Junyu Wu

433 total citations · 1 hit paper
10 papers, 226 citations indexed

About

Junyu Wu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Junyu Wu has authored 10 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Junyu Wu's work include Immune cells in cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Mechanisms and Therapy (2 papers). Junyu Wu is often cited by papers focused on Immune cells in cancer (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Mechanisms and Therapy (2 papers). Junyu Wu collaborates with scholars based in Hong Kong, China and Singapore. Junyu Wu's co-authors include Yibin Feng, Yau-Tuen Chan, Ning Wang, Cheng Zhang, Hongchao Yuan, Yuanjun Lu, Hor‐Yue Tan, Lin Xu, Zixin Feng and Chien‐shan Cheng and has published in prestigious journals such as Molecular Cancer, Journal of Experimental & Clinical Cancer Research and Phytomedicine.

In The Last Decade

Junyu Wu

10 papers receiving 226 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma

2024 68 citations Yau-Tuen Chan, Cheng Zhang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junyu Wu Hong Kong	8	91	62	49	44	32	10	226
Yuchuan Jiang China	9	85 0.9×	58 0.9×	45 0.9×	45 1.0×	49 1.5×	20	224
Tongwang Yang China	10	100 1.1×	46 0.7×	36 0.7×	34 0.8×	30 0.9×	22	263
Anusha Thadi United States	6	116 1.3×	62 1.0×	82 1.7×	39 0.9×	60 1.9×	14	303
Zhu Wang China	8	141 1.5×	70 1.1×	46 0.9×	34 0.8×	20 0.6×	20	274
Sameerah Shaheen Saudi Arabia	10	137 1.5×	75 1.2×	83 1.7×	22 0.5×	15 0.5×	25	314
Keerthi Kurma France	9	122 1.3×	72 1.2×	99 2.0×	53 1.2×	78 2.4×	17	302
Wenbin Hong China	5	173 1.9×	65 1.0×	31 0.6×	83 1.9×	22 0.7×	16	297
Peiqin Wang China	7	187 2.1×	127 2.0×	66 1.3×	29 0.7×	54 1.7×	14	332
Kenji Fukumoto Japan	8	106 1.2×	44 0.7×	60 1.2×	47 1.1×	42 1.3×	18	288

Countries citing papers authored by Junyu Wu

Since Specialization

Citations

This map shows the geographic impact of Junyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyu Wu more than expected).

Fields of papers citing papers by Junyu Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyu Wu. The network helps show where Junyu Wu may publish in the future.

Co-authorship network of co-authors of Junyu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Junyu Wu. A scholar is included among the top collaborators of Junyu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyu Wu. Junyu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Feng, Zixin, Yau-Tuen Chan, Yuanjun Lu, et al.. (2024). Siwu decoction suppress myeloid-derived suppressor cells through tumour cells necroptosis to inhibit hepatocellular carcinoma. Phytomedicine. 133. 155913–155913. 8 indexed citations

2.

Chan, Yau-Tuen, Cheng Zhang, Junyu Wu, et al.. (2024). Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Molecular Cancer. 23(1). 189–189. 68 indexed citations breakdown →

3.

Wu, Junyu, Chien‐shan Cheng, Yau-Tuen Chan, et al.. (2024). Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery. Molecular Cancer. 23(1). 218–218. 14 indexed citations

4.

Lu, Yuanjun, Junyu Wu, Lin Xu, et al.. (2024). Osteoprotegerin mediates adipogenesis in obesity. Journal of Advanced Research. 62. 245–255. 5 indexed citations

5.

Chan, Yau-Tuen, Junyu Wu, Yuanjun Lu, et al.. (2024). Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC. Molecular Cancer. 23(1). 74–74. 29 indexed citations

6.

Wu, Junyu, Hor‐Yue Tan, Yau-Tuen Chan, et al.. (2024). PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer. Journal of Experimental & Clinical Cancer Research. 43(1). 42–42. 14 indexed citations

7.

Wu, Junyu, Yau-Tuen Chan, Yuanjun Lu, et al.. (2023). Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma. International Journal of Biological Sciences. 19(16). 5257–5274. 6 indexed citations

8.

Chan, Yau-Tuen, Hor‐Yue Tan, Yuanjun Lu, et al.. (2023). Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis. Acta Pharmaceutica Sinica B. 13(4). 1554–1567. 29 indexed citations

9.

Lu, Yuanjun, Yau-Tuen Chan, Junyu Wu, et al.. (2023). CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress. Drug Resistance Updates. 71. 101015–101015. 34 indexed citations

10.

Wu, Junyu, Yang Long, Man Li, & Qin He. (2021). Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: Interfering with the crosstalk between “seed and soil”. Acta Pharmaceutica Sinica B. 11(8). 2286–2305. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact